ALKERMES | ALKS - Ação





Ação Alterar Data
AbbVie USD 5.13B 78M 2026-06
Acadia Pharmaceuticals USD 108.67M 77.1M 2026-06
ALKERMES USD 298.96M 37.75M 2026-06
Amgen USD 6.22B 34M 2026-06
Biogen USD 2.38B 435.3M 2026-06
BioMarin Pharmaceutical USD 1.78B 509.3M 2026-06
Bristol-Myers Squibb USD 2.74B 19M 2026-06
Coherus Biosciences USD 5.67M 842K 2026-06
Eli Lilly USD 16.79B 2.26B 2026-06
Gilead Sciences USD 1.91B 140M 2026-03
Heron Therapeutics USD 54.57M 2.33M 2022-12
Ionis Pharmaceuticals USD 50.83M 45.28M 2026-06
J&J USD 15.14B 561M 2026-06
Merck USD 6.21B 272M 2026-06
Nektar Therapeutics USD 14.46M 1.78M 2024-06
Neurocrine Biosciences USD 104.2M 39.7M 2026-06
Otsuka Holdings JPY 374.32B 23.79B 2025-12
Pfizer USD 9.94B 722M 2026-06
Regeneron Pharmaceuticals USD 3.08B 19.3M 2026-06
Vertex Pharmaceuticals USD 1.77B 1.6M 2026-06